Role of Steatosis in Preventing Post-hepatectomy Liver Failure After Major Resection: Findings From an Animal Study [0.03%]
肝切除术后通过动物实验探讨脂肪变性在预防术后肝功能衰竭中的作用
Andrea Lund,Mikkel T Thomsen,Jakob Kirkegård et al.
Andrea Lund et al.
Background/aim: Post-hepatectomy liver failure (PHLF) and hepatic steatosis are evident shortly after extensive partial hepatectomy (PH) in rodents. This study aimed to extrapolate the protein expression and biological pa...
Genes of DLK1-DIO3 Locus and miR-379/656 Cluster is a Potential Diagnostic and Prognostic Marker in Patients With Hepatocellular Carcinoma: A Systems Biology Study [0.03%]
DLK1-DIO3位点及miR-379/656簇基因在肝细胞癌诊断和预后中的潜在生物标志物价值：一项系统生物学研究
Shreyas H Karunakara,Rohit Mehtani,Shama P Kabekkodu et al.
Shreyas H Karunakara et al.
Background: Hepatocellular carcinoma is the sixth most common malignancy reported globally. This highlights the need for reliable biomarkers that can be employed for diagnostic and prognostic applications. The present stu...
Lenvatinib Maintenance Therapy After Complete Response to Atezolizumab Plus Bevacizumab in Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: Alternative Strategy in a Resource-limited Setting [0.03%]
仑伐替尼用于治疗阿特珠单抗联合贝伐珠单抗治疗后的肝癌和门静脉瘤栓完全缓解后的维持疗法：资源有限条件下的替代策略
Pramod Kumar,Rohit Maidur,Adarsh Channagiri et al.
Pramod Kumar et al.
Statin Therapy is Associated With Lower Risk of Mortality Among Liver Transplant Candidates With Metabolic Dysfunction-associated Steatohepatitis [0.03%]
他汀治疗与代谢功能异常相关肝炎终末期肝病等待移植患者预后改善有关
Katherine M Cooper,Ami K Patel,Christopher A Zammitti et al.
Katherine M Cooper et al.
Background: Statin therapy is historically underutilized in patients with chronic liver disease. There is increasing evidence to support the use of statins in patients with cirrhosis, though data in decompensated patients...
Satender P Singh,Tushar Madke,Phool Chand
Satender P Singh
Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and a significant global health challenge due to its high mortality rate. The epidemiology of HCC is closely linked to the prevalence of chronic liver diseases, ...
Prognostic Role of Serum Vascular Endothelial Growth Factor and Hepatocyte Growth Factor Post Stereotactic Body Radiation in Advanced Hepatocellular Carcinoma [0.03%]
立体定向放疗后血清血管内皮生长因子和肝细胞生长因子对晚期肝细胞癌预后的价值
Prabhjyoti Pahwa,Deepti Sharma,Pushpa Yadav et al.
Prabhjyoti Pahwa et al.
Background/aims: Stereotactic body radiation therapy (SBRT) has evolved as a treatment alternative for advanced hepatocellular carcinoma (HCC) patients who are ineligible for other local therapies. Posttreatment responses...
Rohit Mehtani
Rohit Mehtani
Safety and Effectiveness of Naltrexone in the Management of Alcohol Use Disorder in Patients With Alcohol-associated Cirrhosis: First Clinical Observation From Indian Cohort [0.03%]
纳曲酮在酒精性肝硬化患者酒精使用障碍管理中的安全性和有效性：印度队列的首次临床观察
Mohit Varshney,Apinderjit Kaur,Shiv K Sarin et al.
Mohit Varshney et al.
Background and aims: Naltrexone is a promising drug to treat alcohol use disorder with limited evidence of safety in liver diseases. An observational study was performed to study the safety, effectiveness, and tolerabilit...
Monalisa Sahu,Dibyalochan Praharaj,Ajeet S Bhadoria
Monalisa Sahu
Patients with cirrhosis and liver transplant recipients are at increased risk of infections. Malnutrition, multiple hospital admissions, immune dysfunction related to cirrhosis, and immunosuppressive agents used for liver transplantation pr...